BRECA Health Care
Develops custom-made medical implants, prostheses, and surgical guides using 3D printing and bioprinting technologies for complex surgical procedures, with over 200 clinical cases worldwide.
- CEO / Founder
- José Manuel Baena
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $1.1M
- Latest Round
- Grant
- Key Investors
- European research projects; National Spanish projects
Technology & Products
Key Products
Custom cranial implants; Maxillofacial implants; Bone and cartilage reconstruction devices; Pediatric neurosurgery implants; Surgical guides and cutting templates; Bioprinted tissues for regenerative medicine; Lab-on-a-chip kits for antitumoral treatments
Technological Advantage
Verified advantage: Over 200 clinical cases demonstrate real-world efficacy in pediatric neurosurgery and complex reconstructions. Defensible through proprietary bioink formulations and custom design software, though some aspects may be replicable by competitors.
Differentiation
Value Proposition
Reduces surgical planning time by up to 70% and improves patient outcomes through personalized, patient-specific medical devices that enhance precision and reduce complications in complex surgeries.
How They Differentiate
Focuses exclusively on custom medical devices with bioprinting integration, unlike broader 3D printing companies; offers end-to-end solutions from design to clinical validation, whereas competitors often provide hardware or software only.
Market & Competition
Target Customers
Medical professionals, healthcare institutions, hospitals, surgeons
Industry Verticals
Healthcare; Medical Devices; Biotechnology; Regenerative Medicine
Competitors
REGEMAT 3D (affiliated bioprinting hardware); 3D Systems (medical 3D printing solutions); Stratasys (medical applications of 3D printing); Materialise (medical software and 3D printing services)
Growth & Milestones
Growth Metrics
Over 200 clinical cases completed worldwide; products registered in EU, Colombia, Costa Rica, and Mexico; expanding into US market.
Major Milestones
Founded in 2011; Completed 200+ clinical cases; Registered products in multiple countries; Developing bioprinting for cornea regeneration and butterfly skin biomaterials
Notable Customers
University Hospital of La Paz (Madrid, Spain); PITI3D (3D Tissue Engineering and Printing Platform at University Hospital of La Paz)